Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
BPMC Quote, Financials, Valuation and Earnings
Last price:
$129.49
Seasonality move
:
2.16%
Day range:
$129.20 - $129.65
52-week range:
$73.04 - $129.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.74x
P/B ratio:
24.40x
Volume:
25.7M
Avg. volume:
5.2M
1-year change:
7.29%
Market cap:
$8.3B
Revenue:
$508.8M
EPS (TTM):
-$2.47
Earnings Data
Next earnings date for BPMC
Aug 01
2025
Most recent earnings per share
$0.01
Beat by $0.45
(May 1/2025)
Consensus Estimate
-$0.44
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BPMC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $191.1M | -- | -- | -$0.29 | -- |
| 08/01/2025 | Q2 | $171.3M | -- | -- | -$0.53 | -- |
| 05/01/2025 | Q1 | $156.9M | $149.4M | $0.01 | -$0.44 | $0.45 |
| 02/13/2025 | Q4 | $145.2M | $146.4M | -$0.79 | -$0.73 | -$0.06 |
| 10/30/2024 | Q3 | $127.5M | $128.2M | -$0.89 | -$0.96 | $0.07 |
| 08/01/2024 | Q2 | $103.9M | $138.2M | -$0.80 | -$1.25 | $0.45 |
| 05/02/2024 | Q1 | $81.4M | $96.1M | $1.40 | -$1.67 | $3.07 |
| 02/15/2024 | Q4 | $67.1M | $72M | -$1.82 | -$2.06 | $0.24 |
| 10/26/2023 | Q3 | -- | -- | -$2.20 | -$2.33 | $0.13 |
| 08/02/2023 | Q2 | -- | -- | -$2.19 | -$2.49 | $0.30 |
| 05/04/2023 | Q1 | -- | -- | -$2.15 | -$2.62 | $0.47 |
| 02/16/2023 | Q4 | -- | -- | -$2.65 | -$2.61 | -$0.04 |
| 11/01/2022 | Q3 | -- | -- | -$2.23 | -$2.49 | $0.26 |
| 08/02/2022 | Q2 | -- | -- | -$2.68 | -$2.26 | -$0.42 |
| 05/03/2022 | Q1 | -- | -- | -$1.79 | -$1.85 | $0.06 |
| 02/16/2022 | Q4 | -- | -- | -$5.40 | -$1.57 | -$3.83 |
| 10/28/2021 | Q3 | -- | -- | -$2.00 | -$1.66 | -$0.34 |
| 07/29/2021 | Q2 | -- | -- | -$1.86 | -$1.92 | $0.05 |
| 04/29/2021 | Q1 | -- | -- | -$1.72 | -$1.82 | $0.10 |
| 02/17/2021 | Q4 | -- | -- | -$1.53 | -$1.55 | $0.02 |
| 10/29/2020 | Q3 | -- | -- | $11.16 | $9.30 | $1.86 |
| 07/30/2020 | Q2 | -- | -- | -$2.28 | -$2.08 | -$0.20 |
| 05/06/2020 | Q1 | -- | -- | -$2.11 | -$2.01 | -$0.10 |
| 02/13/2020 | Q4 | -- | -- | -$1.35 | -$1.73 | $0.38 |
| 11/05/2019 | Q3 | -- | -- | -$1.93 | -$2.17 | $0.24 |
| 08/01/2019 | Q2 | -- | -- | -- | -$1.90 | -- |
| 05/09/2019 | Q1 | -- | -- | -- | -$1.89 | -- |
| 02/26/2019 | Q4 | -- | -- | -- | -$1.72 | -- |
| 10/30/2018 | Q3 | -- | -- | -- | -$1.61 | -- |
| 08/01/2018 | Q2 | -- | -- | -- | -- | -- |
| 05/02/2018 | Q1 | -- | -- | -- | -- | -- |
| 02/21/2018 | Q4 | -- | -- | -- | -- | -- |
| 10/31/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/02/2017 | Q2 | -- | -- | -- | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -- | -- | -- |
| 03/09/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/10/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/10/2016 | Q1 | -- | -- | -- | -- | -- |
| 03/14/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -- | -- | -- |
Blueprint Medicines Earnings Questions
-
How Much did Blueprint Medicines Generate in Revenue Last Quarter?
Blueprint Medicines reported $149.4M worth of top line sales in its most recent quarter.
-
Did Blueprint Medicines Beat Earnings Last Quarter?
Blueprint Medicines announced earnings per share of $0.01 which represents a beat of analyst forecast a -$0.44 per share.
-
Is Blueprint Medicines Profitable?
Blueprint Medicines reported $146.6M that represents $2.20 per share over the last quarter.
-
What is the Analyst Consensus for Blueprint Medicines EPS Next Year?
Blueprint Medicines's earnings are forecast to decrease from -$1.07 per share to -$1.05 per share next year representing a decrease of -58.51%.
-
When is Blueprint Medicines's Earnings Date?
Blueprint Medicines's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
